Publication | Closed Access
Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer
85
Citations
87
References
2018
Year
Oral Recombinant MethioninaseOncologyPancreatic CancerMedicineGemcitabine ResistancePancreatic SurgeryPharmacologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1